chartexchange

CTMX
CytomX Therapeutics, Inc.
stockNASDAQ

At CloseNov 18, 2026 3:59:57 PM EST
1.88USD-2.835%(-0.06)4,386,510
Pre-marketNov 18, 2026 9:29:30 AM EST
2.02USD+4.124%(+0.08)
After-hoursNov 18, 2026 4:34:30 PM EST
1.90USD+0.796%(+0.02)
1.6300Bid2.2800Ask0.6500Spread

CTMX Financials

In Q3 FY 2026 (ended ), CytomX Therapeutics, Inc. (CTMX) reported revenue of $1.69M, net income of −$20M, operating cash flow of $16.65M, and assets of $364.68M (filed ).

Loading financial statements…